Research article summary (published 21 Jun 2007):

VALIDD should not invalidate angiotensin-receptor blockers.

Full Abstract

No abstract is currently available for this article. See 'Journal and Publication Information' further down the page for details that may assist you in locating this article in electronic or hard copy media. The 'Related articles' section also further down the page, where available, may show links to abstracts of articles covering similar topics.

Author information

Author/s: Ahmed, Ali (A); Perry, Gilbert J (GJ); Husain, Ahsan (A);

Affiliation: Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA. aahmed(-atsign-)uab.edu

Journal and publication information

Publication Type: Comment; Journal Article

Journal: Lancet (Lancet), published in England. (Language: eng)

Reference: 2007-Jun; vol 369 (issue 9579) : pp 2053-4

Dates: Created 2007/06/25; Completed 2007/07/03; Revised 2007/11/15;

PMID: 17586284, status: MEDLINE (last retrieved date: 2/18/2009)

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

Comments and Corrections

CommentOn: Lancet. 2007 Jun 23;369(9579):2079-87. (PMID: 17586303)

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.

MeSH headings (categories)

This article was linked to the MeSH Headings (categories) shown below.

Angiotensin II Type 1 Receptor Blockers - pharmacology; therapeutic use Blood Pressure - drug effects Female Humans Hypertension - complications; drug therapy Hypertrophy, Left Ventricular - complications; etiology

Hypertrophy, Left Ventricular - complications; etiology Myocardial Infarction - etiology; prevention & control Randomized Controlled Trials as Topic Renin-Angiotensin System - drug effects; physiology Tetrazoles - pharmacology; therapeutic use Valine - analogs & derivatives; pharmacology; therapeutic use

Note: Bold headings indicate primary MeSH headings or qualifiers.

Associated Chemicals: Angiotensin II Type 1 Receptor Blockers (0) ; Tetrazoles (0) ; valsartan (137862-53-4) ; Valine (7004-03-7)

Related articles

These are the most related articles currently in our database:

• Comparative efficacy of valsartan and olmesartan in mild-to-moderate hypertension: results of 24-hour ambulatory blood pressure monitoring. 30 Dec 2004
• Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial. 21 Jun 2007
• [VALUE] 30 Jul 2006
• Blockade of the renin-angiotensin system: better late than never. 30 May 2004
• Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study. 30 May 2007
• [Angiotensin II receptor blockers: current status and future prospects] 30 Dec 2001
• Bradykinin B(2) receptor does not contribute to blood pressure lowering during AT(1) receptor blockade. 18 Dec 2006
• Use of valsartan in post-myocardial infarction and heart failure patients. 30 May 2006
• Cardiac angiotensin is upregulated in the hearts of unstable angina patients. 23 Jun 2004
• A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours. 30 Dec 2005

See 100+ related articles.

Related Article Map

Legend: - FREE Full text Article. - Abstract only. - Title only. More help.

See a larger map of 100+ related articles.